Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07524335 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Aspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Controlled Trial

Study acronym: ASCAD-P
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 months later May 1, 2027 → Jul 21, 2027
See other at-risk trials from Montreal Heart Institute

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened Show 7 more changesShow less
    • Primary completion pushed from May 1, 2027 to Jul 21, 2027
    • Study completion moved earlier from May 1, 2028 to Jan 2028
    • Start date changed from estimate of May 1, 2026 to Jul 21, 2026
    • Eligibility criteria expanded, about 11 words
    • Secondary endpoints: details revised at 4 of 5 entries
    • Study description expanded, about 9 words
    • Site details revised
  2. Secondary endpoints: details revised at 1 of 5 entriesv3
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In patients with subclinical coronary artery disease, the ASCAD-P study aims to assess the feasibility of a larger phase 3 pragmatic randomized controlled trial comparing prescription versus no prescription of low-dose aspirin in routine clinical practice.
Trial Details
NCT Number NCT07524335
Lead Sponsor Montreal Heart Institute
Conditions
(from sponsor)		 Coronary Artery Disease, Subclinical Atherosclerotic Cardiovascular Disease
Related terms Coronary Artery Disease, Hemorrhage
Enrollment 48 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov